An update on acute ischemic stroke therapies.
Given its short therapeutic time window, successful ischemic stroke therapy requires a multi-disciplinary and streamlined approach. Intravenous recombinant tissue plasminogen activator remains the most efficacious treatment available. New therapies and advances in the understanding comorbidities associated with stroke have reshaped and expanded traditional treatment.
Szewka
Aimee Joy
AJ
Department of Neurological Sciences, Section of Cerebrovascular Disease and Neurologic Critical Care, Rush University Medical Center, 1725 W. Harrison Street, Suite 1121, Chicago, IL 60612, USA.
Prabhakaran
Shyam
S
D002985:Clinical Protocols; D004630:Emergencies; D006801:Humans; D009460:Neurologic Examination; D020521:Stroke / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000379:methods; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use
D010959:Tissue Plasminogen Activator